Krsnaa Diagnostics Shareholding Pattern
- Market cap
- ₹1,719 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹381.60 – ₹715.50
As of Jun 2026, promoters held 48.50% of Krsnaa Diagnostics, foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 9 October 2026. How this data is compiled.
Krsnaa Diagnostics shareholding pattern — frequently asked questions
What is the promoter holding in Krsnaa Diagnostics?
Promoters held 48.50% of Krsnaa Diagnostics as of Jun 2026.
How much do FIIs hold in Krsnaa Diagnostics?
Foreign institutional investors held 18.40% of Krsnaa Diagnostics as of Jun 2026.
How much do domestic institutions hold in Krsnaa Diagnostics?
Domestic institutional investors, including mutual funds and insurers, held 14.20% of Krsnaa Diagnostics as of Jun 2026; mutual funds alone held 8.50%.
Who owns Krsnaa Diagnostics?
As of Jun 2026, Krsnaa Diagnostics' shareholders were promoters (48.50%), foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%, as filed with the stock exchanges.
Same Data For Peers
- Dr. Lal Path Labs Limited. shareholding pattern
- Krishna Institute of Medical Sciences Limited shareholding pattern
- Laurus Labs Limited shareholding pattern
- Kilitch Drugs (India) Limited shareholding pattern
- Lincoln Pharmaceuticals Limited shareholding pattern
- Jubilant Pharmova Limited shareholding pattern
Trade Krsnaa Diagnostics With ATS
Track KRSNAA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.